RMCP > MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Revolutions Medical Corp (OTC:RMCP - News) has set certain goals for this summer that when completed should add value to its stock. These goals should propel the company forward as it enters the sales and marketing phase of its business plan. The company has been working towards 510K FDA submission for its RevVac safety syringe for the past several months. Its first goal is to complete and file this submission for all sizes of its safety syringe including 1cc, 3cc, 5cc, and 10cc with the FDA. Rev Med has hired and announced the two companies that are handling the submittal and the lab testing: Strategic Product Development and SHAKERZANDMOVERZ LLC HAS BEEN COMPENSATED 35,000.00 IN CASH FOR MARKET AWARENESS >3RD PARTY > CHECK DISCLAIMOR
